Latest filing published 09 Oct 2026 for Immunovant, Inc., €64k. Read the official filing
Melanie Gloria, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Immunovant, Inc. and ACELYRIN, Inc. In total, 14 filings cover trades dated from 16 August 2023 to 7 October 2026.
The open-market record consists of 9 sales worth €678k, with no purchase. The totals exclude 2 filings filed without an amount. The rest of the record consists of 5 share grants. So far in 2026, the count stands at no purchases and 8 sales.
The latest filing, published on 9 October 2026, reports an open-market sale of €64k in Immunovant, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations